BRIEF published on 04/02/2024 at 15:05, 2 years 7 months ago Edesa Biotech participera aux prochaines conférences d'investisseurs Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs
PRESS RELEASE published on 04/02/2024 at 15:00, 2 years 7 months ago Edesa Biotech to Participate in Upcoming Investor Conferences Edesa Biotech, Inc. announces participation in upcoming investor conferences in Toronto, London, and New York to present innovative treatments for immuno-inflammatory diseases Clinical-stage Biopharmaceutical Company Immuno-inflammatory Diseases Investor Conferences Edesa Biotech Inc. Therapeutics
BRIEF published on 03/21/2024 at 21:35, 2 years 7 months ago Edesa Biotech participera à la conférence HC Wainwright sur les maladies auto-immunes et inflammatoires Maladies Inflammatoires Edesa Biotechnologie Conférence Auto-immune Discussion Au Coin Du Feu Produits Biopharmaceutiques Au Stade Clinique
BRIEF published on 03/21/2024 at 21:35, 2 years 7 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Fireside Chat Edesa Biotech Inflammatory Diseases Autoimmune Conference Clinical-Stage Biopharmaceutical
PRESS RELEASE published on 03/21/2024 at 21:30, 2 years 7 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Edesa Biotech to participate in H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference. Fireside Chat with CEO Par Nijhawan, MD and analyst scheduled for March 28, 2024 Fireside Chat Edesa Biotech H.C. Wainwright Autoimmune & Inflammatory Disease Par Nijhawan
BRIEF published on 03/07/2024 at 14:50, 2 years 8 months ago Edesa Biotech to Showcase at Barclays Global Healthcare Conference Clinical Trials Edesa Biotech Immunotherapy Barclays Healthcare Conference ARDS
BRIEF published on 03/07/2024 at 14:50, 2 years 8 months ago Edesa Biotech sera présent à la conférence Barclays Global Healthcare Immunothérapie Essais Cliniques Edesa Biotechnologie Conférence Barclays Sur La Santé SDRA
PRESS RELEASE published on 03/07/2024 at 14:45, 2 years 8 months ago Edesa Biotech to Participate in Barclays Global Healthcare Conference Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Barclays 26th Annual Global Healthcare Conference in Miami. Company focuses on developing host-directed therapeutics for immuno-inflammatory diseases Biopharmaceutical Company Edesa Biotech NASDAQ:EDSA Barclays 26th Annual Global Healthcare Conference Immune-related Diseases
BRIEF published on 03/04/2024 at 22:35, 2 years 8 months ago Edesa Biotech participera aux prochaines réunions de dermatologie Biopharmaceutique Essais Cliniques Edesa Biotechnologie Dermatologie Maladies Immuno-inflammatoires
BRIEF published on 03/04/2024 at 22:35, 2 years 8 months ago Edesa Biotech to Participate in Upcoming Dermatology Meetings Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Dermatology
Published on 11/12/2026 at 15:55, 47 minutes ago DIAGENS Leads in Two Major Global AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets, Ushering in a New Era for Medical Imaging AI
Published on 11/12/2026 at 14:31, 2 hours 11 minutes ago First Breach Inc. Announces Third Quarter 2026 Earnings Conference Call
Published on 11/12/2026 at 14:00, 2 hours 42 minutes ago GameSquare Announces Peaky Blinders Digital Fan Experience, Advancing the Company's IP Monetization Strategy
Published on 11/12/2026 at 14:00, 2 hours 42 minutes ago NuRAN Wireless Highlights Recurring Revenue Economics and Growth Potential of Its 5,092-Tower Contracted NaaS Portfolio
Published on 11/12/2026 at 13:45, 2 hours 57 minutes ago Amarc and Freeport Successfully Complete 2026 Joy Copper-Gold District Exploration Program
Published on 11/12/2026 at 16:29, 12 minutes ago Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
Published on 11/12/2026 at 16:06, 36 minutes ago Leadership change at GEA: Klaus Stojentin to succeed Stefan Klebert as CEO
Published on 11/12/2026 at 16:05, 37 minutes ago Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
Published on 11/12/2026 at 16:05, 37 minutes ago EQS-Adhoc: GEA Group Aktiengesellschaft: Stefan Klebert to leave the Executive Board of GEA Group Aktiengesellschaft after the 2027 Annual General Meeting; his successor will be Klaus Stojentin
Published on 11/12/2026 at 08:56, 7 hours 45 minutes ago Number of shares and voting rights - October 2026 (In French only)
Published on 11/12/2026 at 08:56, 7 hours 45 minutes ago Nombre total d'actions et droits de vote - octobre 2026
Published on 11/12/2026 at 08:40, 8 hours 2 minutes ago FREY forms a €400 million equity partnership with GIC to invest in premium European retail parks
Published on 11/12/2026 at 08:40, 8 hours 2 minutes ago FREY et GIC s’associent pour investir 400 M€ de capital dans les retail parks premium en Europe
Published on 11/10/2026 at 18:00, 1 day 22 hours ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
